首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist.
【24h】

Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist.

机译:促性腺激素释放激素激动剂对复发性侵袭性血管瘤的医疗管理。

获取原文
获取原文并翻译 | 示例
       

摘要

Patients with aggressive angiomyxoma may experience local recurrences. We report a case of recurrent aggressive angiomyxoma medically treated successfully with a gonadotropin-releasing hormone agonist. A 34-year-old woman with a huge perineal tumor underwent an extensive resection of the abdominoperineal tumor combined with total pelvic exenteration. Histology showed aggressive angiomyxoma and the tumor cells were immunoreactive for estrogen and progesterone receptors. Although the patient had experienced no local recurrence for 12 months under adjuvant therapy with a gonadotropin-releasing hormone agonist, a recurrence occurred 3 months after the completion of adjuvant therapy. The patient underwent medical treatment with a gonadotropin-releasing hormone agonist and had a complete resolution of the recurrent tumor again. Hormonal treatment with a gonadotropin-releasing hormone agonist can be applied for small primary aggressive angiomyxomas in addition to adjuvant therapy for residual tumors.
机译:侵袭性血管粘液瘤患者可能会出现局部复发。我们报告一例复发性侵袭性血管平滑肌瘤,成功治疗了促性腺激素释放激素激动剂。一名患有巨大会阴肿瘤的34岁妇女接受了腹部手术肿瘤的广泛切除,并合并了盆腔全切除术。组织学显示侵袭性血管粘液瘤,并且肿瘤细胞对雌激素和孕激素受体具有免疫反应性。尽管在使用促性腺激素释放激素激动剂进行辅助治疗的情况下,患者在12个月内未出现局部复发,但在完成辅助治疗后3个月出现了复发。该患者接受了促性腺激素释放激素激动剂的药物治疗,再次完全治愈了复发性肿瘤。除对残留肿瘤的辅助治疗外,用促性腺激素释放激素激动剂进行的激素治疗还可用于小型原发性侵袭性血管粘液瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号